Search - tctmd.com

Displaying 461 - 480 of 568

Sort: Relevancy | Date

Presentation TCT 2013

Left Atrial Appendage Occlusion: A Valid Option to Anticoagulation for Long-term Prevention of Stroke

Presenter: Saibal Kar

October 29, 2013

Presentation TCT 2013

A Cost Benefit Analysis of Left Atrial Appendage Closure Versus Warfarin for Stroke Prevention in Atrial Fibrillation

Presenter: Vivek Y. Reddy

October 29, 2013

Presentation TCT 2013

Prevention of Radial Artery Injury

Presenter: Sudhir Rathore

October 28, 2013

Presentation TCT 2013

BOSS: A Prospective, Randomized Trial of Bicarbonate vs. Saline for Prevention of Contrast Nephropathy

Presenter: Richard Solomon

October 28, 2013

Presentation TCT 2013

Aspirin and ADP Antagonists Pre- and Post-coronary Stent Implantation

Presenter: Dmitriy Feldman

October 28, 2013

Presentation TCT 2013

The Mediterranean Diet: Should This Be a Mainstay of Prevention?

Presenter: Piera Capranzano

October 27, 2013

Presentation TCT 2013

Multicenter Experience with the ACP for Stroke Prevention in Atrial Fibrillation

Presenter: Apostolos Tzikas

October 27, 2013

Presentation

Duration of Dual Antiplatelet Treatment with Clopidogrel and Aspirin in Patients with ACS

Presenter: Christoph Varenhorst

October 18, 2013

Presentation

Optimal Duration Of Dual Antiplatelet Therapy After DES Implantation

Presenter: C.W. Lee

October 10, 2013

Presentation

Short-term Rosuvastatin for Prevention of Contrast-Induced Acute Kidney Injury (CI-AKI) in Patients with Diabetes and Chronic Kidney Disease

Presenter: Yaling Han

October 09, 2013

Presentation

PRATO-ACS: Early High-Dose Rosuvastatin for Contrast-Induced Nephropathy Prevention in ACS

Presenter: M. Leoncini

October 09, 2013

Presentation

Clinical Outcomes of PCI Performed Without Preprocedural Aspirin

Presenter: M. Kenaan

October 02, 2013

Presentation ESC 2013

Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI):Results from the Real-World PARIS Registry

Presenter: 32040|Roxana Mehran

September 01, 2013

Presentation

Triple Antithrombotic Therapy Is the Independent Predictor of Major Bleeding Complications

Presenter: Y. Naruse

August 26, 2013

Presentation

Systematic Review of Oral Sirolimus After Bare-Metal Stenting of Coronary Arteries for Prevention of In-Stent Restenosis

Presenter: Tarun W. Dasari

August 21, 2013

Presentation

The Effects of Apixaban on Hospitalizations in Patients With Different Types of Atrial Fibrillation

Presenter: Stefan H. Hohnloser

August 01, 2013

Presentation SOLACI 2013

State of the Art in CIN Prevention: Insights from Recent Trials

Presenter: Otavio Berwanger

July 26, 2013

Presentation

Use and Associated Risks of Concomitant Aspirin with Oral Anticoagulation in A-fib Patients

Presenter: B. A. Steinberg

July 24, 2013

Presentation SOLACI 2013

Technologies for Embolic Prevention in STEMI PCI

Presenter: David Antoniucci

July 24, 2013

Presentation SOLACI 2013

DAPT for ACS: Focus on Patient Secondary Prevention

Presenter: Roberto Botelho

July 24, 2013

Advertisement

Left Atrial Appendage Occlusion: A Valid Option to Anticoagulation for Long-term Prevention of Stroke

A Cost Benefit Analysis of Left Atrial Appendage Closure Versus Warfarin for Stroke Prevention in Atrial Fibrillation

Prevention of Radial Artery Injury

BOSS: A Prospective, Randomized Trial of Bicarbonate vs. Saline for Prevention of Contrast Nephropathy

Aspirin and ADP Antagonists Pre- and Post-coronary Stent Implantation

The Mediterranean Diet: Should This Be a Mainstay of Prevention?

Multicenter Experience with the ACP for Stroke Prevention in Atrial Fibrillation

Duration of Dual Antiplatelet Treatment with Clopidogrel and Aspirin in Patients with ACS

Optimal Duration Of Dual Antiplatelet Therapy After DES Implantation

Short-term Rosuvastatin for Prevention of Contrast-Induced Acute Kidney Injury (CI-AKI) in Patients with Diabetes and Chronic Kidney Disease

PRATO-ACS: Early High-Dose Rosuvastatin for Contrast-Induced Nephropathy Prevention in ACS

Clinical Outcomes of PCI Performed Without Preprocedural Aspirin

Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI):Results from the Real-World PARIS Registry

Triple Antithrombotic Therapy Is the Independent Predictor of Major Bleeding Complications

Systematic Review of Oral Sirolimus After Bare-Metal Stenting of Coronary Arteries for Prevention of In-Stent Restenosis

The Effects of Apixaban on Hospitalizations in Patients With Different Types of Atrial Fibrillation

State of the Art in CIN Prevention: Insights from Recent Trials

Use and Associated Risks of Concomitant Aspirin with Oral Anticoagulation in A-fib Patients

Technologies for Embolic Prevention in STEMI PCI

DAPT for ACS: Focus on Patient Secondary Prevention

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content